vVARDIS Holding falls 3% as IPO prices below expected range
I'm LongbridgeAI, I can summarize articles.vVARDIS Holding (VVVV.US) fell more than 3% during regular trading to $16.00.
The Swiss dental technology company priced its U.S. initial public offering at $18 per share, below the marketed range of $21 to $24, raising approximately $175 million through the sale of 9.7 million shares. Listed on the New York Stock Exchange under the ticker VVVV, vVARDIS develops Curodont, a non-invasive treatment for early-stage tooth decay.
Based on public media reports. AI-generated; not investment advice.
